TABLE 2.
Magnitude and significance of DNA effects on incubation perioda
| DNA treatment | Effect of treatment at the following CRPV challenge stringency:
|
|||||
|---|---|---|---|---|---|---|
| High
|
Moderate
|
Low
|
||||
| Dayb | P | Dayb | P | Dayb | P | |
| Control | 20.3 | NA | 24.0 | NA | 24.0 | NA |
| E6 only | 24.8 | 0.0700 | 49.2 | 0.0503 | 56.8 | 0.0148 |
| GM-CSF only | 25.8 | 0.0334 | 24.0 | NS | 24.0 | 0.0490 |
| GM-CSF + E6 | 30.3 | No interaction | 46.7 | No interaction | 76.3 | No interaction |
a
The data are based on maximum-likelihood estimates. NS, not significant at a P value of <0.10. NA, not applicable. No interaction, an additive model fits the data.
b
Mean number of days after CRPV challenge preceding papilloma onset.